 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
Anti-smoking Drug Decreases Alcohol Consumption in Heavy-drinking Smokers |
UCSF Gallo scientists show that drinking releases brain endorphins: study offers possible clue to why alcohol is addicting |
Jennifer Whistler, PhD, receives $825,500 research award from Novo Nordisk |
FDA-Approved drug might prevent relapse in male alcoholics |
Howard Fields & Jennifer Mtichell |
 |
 |
 |
The smoking cessation drug varenicline significantly reduced alcohol consumption in a group of heavy-drinking smokers, in a study carried out by researchers at the Ernest Gallo Clinic and Research Center. |
Drinking alcohol leads to the release of endorphins in areas of the brain that produce feelings of pleasure and reward, according to a study led by researchers at the Ernest Gallo Clinic and Research Center. |
Jennifer Whistler, PhD, a principal investigator at the UCSF Ernest Gallo Clinic and Research Center, has received a two-year, $825,500 Diabetes Innovation Award from Novo Nordisk, an international health care company based in Denmark. |
Mifepristone, a drug approved by the Food and Drug Administration for terminating early pregnancy, might prove effective in preventing stress-induced relapse in recovering male alcoholics, based on findings in rats reported by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco. |
| CONTACT US 5858 Horton Street, Suite 200 Emeryville, CA 94608 Phone: (510) 985-3109 |
